FDA Drug Application (203823) for OXYCODONE HYDROCHLORIDE by LANNETT HOLDINGS INC

Back to FDA Applications sponsored by LANNETT HOLDINGS INC

Application Number203823
Product Number001
FormCAPSULE;ORAL
Dosage5MG
Product Market Status Prescription
Therapeutic Equivalence Evaluation Code AB Products meeting necessary bioequivalence requirements
Reference Drug
Drug NameOXYCODONE HYDROCHLORIDE
Active IngredientOXYCODONE HYDROCHLORIDE

Active IngredientCount
List of drugs with Active Ingredient OXYCODONE HYDROCHLORIDE27


Back to FDA Applications sponsored by LANNETT HOLDINGS INC